Cost versus utility of aclidinium bromide 400 µg plus formoterol fumarate dihydrate 12 µg compared to aclidinium bromide 400 µg alone in the management of moderate-to-severe COPD

PURPOSE: Aclidinium–formoterol 400/12 µg is a long-acting muscarinic antagonist (LAMA) and a long-acting β(2)-agonist in a fixed-dose combination used in the management of patients with COPD. This study aimed to assess the cost-effectiveness of aclidinium–formoterol 400/12 µg against the long-acting...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramos, Mafalda, Haughney, John, Henry, Nathaniel, Lindner, Leandro, Lamotte, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5026215/
https://www.ncbi.nlm.nih.gov/pubmed/27672337
http://dx.doi.org/10.2147/CEOR.S107121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5026215/
https://www.ncbi.nlm.nih.gov/pubmed/27672337
http://dx.doi.org/10.2147/CEOR.S107121

Ejemplares similares